Chronobiology of Bipolar Disorder: Therapeutic Implication

Overview

Journal Curr Psychiatry Rep

Publisher Current Science

Specialty Psychiatry

Date 2015 Jun 27

PMID 26112914

Citations 17

Authors

Sara Dallaspezia

Francesco Benedetti

Affiliations

Soon will be listed here.

Abstract

Multiple lines of evidence suggest that psychopathological symptoms of bipolar disorder arise in part from a malfunction of the circadian system, linking the disease with an abnormal internal timing. Alterations in circadian rhythms and sleep are core elements in the disorders, characterizing both mania and depression and having recently been shown during euthymia. Several human genetic studies have implicated specific genes that make up the genesis of circadian rhythms in the manifestation of mood disorders with polymorphisms in molecular clock genes not only showing an association with the disorder but having also been linked to its phenotypic particularities. Many medications used to treat the disorder, such as antidepressant and mood stabilizers, affect the circadian clock. Finally, circadian rhythms and sleep researches have been the starting point of the developing of chronobiological therapies. These interventions are safe, rapid and effective and they should be considered first-line strategies for bipolar depression.

Citing Articles

Role of adjunctive nonpharmacological strategies for treatment of rapid-cycling bipolar disorder.

Chakrabarti S, Jolly A, Singh P, Yadhav N World J Psychiatry. 2023; 13(8):495-510.

PMID: 37701540 PMC: 10494771. DOI: 10.5498/wjp.v13.i8.495.

Privacy-Preserving Federated Model Predicting Bipolar Transition in Patients With Depression: Prediction Model Development Study.

Lee D, Choi B, Kim C, Fridgeirsson E, Reps J, Kim M J Med Internet Res. 2023; 25:e46165.

PMID: 37471130 PMC: 10401196. DOI: 10.2196/46165.

Pharmacotherapeutic management of insomnia and effects on sleep processes, neural plasticity, and brain systems modulating stress: A narrative review.

Palagini L, Bianchini C Front Neurosci. 2022; 16:893015.

PMID: 35968380 PMC: 9374363. DOI: 10.3389/fnins.2022.893015.

Spectrophotometric properties of commercially available blue blockers across multiple lighting conditions.

Mason B, Tubbs A, Fernandez F, Grandner M Chronobiol Int. 2022; 39(5):653-664.

PMID: 34983271 PMC: 9106867. DOI: 10.1080/07420528.2021.2021229.

Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects.

Ilan Y Mol Ther Methods Clin Dev. 2020; 18:335-344.

PMID: 32671136 PMC: 7341037. DOI: 10.1016/j.omtm.2020.06.006.

References

Geoffroy P, Bellivier F, Scott J, Etain B . Seasonality and bipolar disorder: a systematic review, from admission rates to seasonality of symptoms. J Affect Disord. 2014; 168:210-23. DOI: 10.1016/j.jad.2014.07.002. View

Krueger J . The role of cytokines in sleep regulation. Curr Pharm Des. 2008; 14(32):3408-16. PMC: 2692603. DOI: 10.2174/138161208786549281. View

Ellenbogen M, Santo J, Linnen A, Walker C, Hodgins S . High cortisol levels in the offspring of parents with bipolar disorder during two weeks of daily sampling. Bipolar Disord. 2010; 12(1):77-86. DOI: 10.1111/j.1399-5618.2009.00770.x. View

Canali P, Sferrazza Papa G, Casali A, Schiena G, Fecchio M, Pigorini A . Changes of cortical excitability as markers of antidepressant response in bipolar depression: preliminary data obtained by combining transcranial magnetic stimulation (TMS) and electroencephalography (EEG). Bipolar Disord. 2014; 16(8):809-19. DOI: 10.1111/bdi.12249. View

Nurnberger Jr J, Berrettini W, Tamarkin L, Hamovit J, Norton J, Gershon E . Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. A preliminary report. Neuropsychopharmacology. 1988; 1(3):217-23. DOI: 10.1016/0893-133x(88)90020-6. View

Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C . Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. Neurosci Lett. 2005; 376(1):51-5. DOI: 10.1016/j.neulet.2004.11.022. View

Freland L, Beaulieu J . Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci. 2012; 5:14. PMC: 3282483. DOI: 10.3389/fnmol.2012.00014. View

Terman M . Evolving applications of light therapy. Sleep Med Rev. 2007; 11(6):497-507. DOI: 10.1016/j.smrv.2007.06.003. View

Kripke D, Wyborney V . Lithium slows rat circadian activity rhythms. Life Sci. 1980; 26(16):1319-21. DOI: 10.1016/0024-3205(80)90091-0. View

10.

Benedetti F, Dallaspezia S, Cigala Fulgosi M, Lorenzi C, Serretti A, Barbini B . Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B(5):631-5. DOI: 10.1002/ajmg.b.30475. View

11.

Kishi T, Kitajima T, Ikeda M, Yamanouchi Y, Kinoshita Y, Kawashima K . Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. Neurosci Res. 2008; 62(4):211-5. DOI: 10.1016/j.neures.2008.08.008. View

12.

Benedetti F, Terman M . Much ado about…a moody clock. Biol Psychiatry. 2013; 74(4):236-7. DOI: 10.1016/j.biopsych.2013.05.037. View

13.

Geoffroy P, Boudebesse C, Bellivier F, Lajnef M, Henry C, Leboyer M . Sleep in remitted bipolar disorder: a naturalistic case-control study using actigraphy. J Affect Disord. 2014; 158:1-7. DOI: 10.1016/j.jad.2014.01.012. View

14.

Kennedy S, Kutcher S, Ralevski E, Brown G . Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res. 1996; 63(2-3):219-22. DOI: 10.1016/0165-1781(96)02910-1. View

15.

Katzenberg D, Young T, Finn L, Lin L, King D, Takahashi J . A CLOCK polymorphism associated with human diurnal preference. Sleep. 1998; 21(6):569-76. DOI: 10.1093/sleep/21.6.569. View

16.

Severino G, Manchia M, Contu P, Squassina A, Lampus S, Ardau R . Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system. Bipolar Disord. 2009; 11(2):215-20. DOI: 10.1111/j.1399-5618.2009.00667.x. View

17.

Riemann D, Voderholzer U, Berger M . Sleep and sleep-wake manipulations in bipolar depression. Neuropsychobiology. 2002; 45 Suppl 1:7-12. DOI: 10.1159/000049255. View

18.

Gould T, Manji H . Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology. 2005; 30(7):1223-37. DOI: 10.1038/sj.npp.1300731. View

19.

BECK-FRIIS J, Ljunggren J, Thoren M, von Rosen D, Kjellman B, Wetterberg L . Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology. 1985; 10(2):173-86. DOI: 10.1016/0306-4530(85)90055-1. View

20.

Havermans R, Nicolson N, Berkhof J, deVries M . Patterns of salivary cortisol secretion and responses to daily events in patients with remitted bipolar disorder. Psychoneuroendocrinology. 2010; 36(2):258-65. DOI: 10.1016/j.psyneuen.2010.07.016. View